Diclofenac (DCF) can cause adverse reactions such as gastrointestinal, renal and cardiovascular disorders; therefore, topical administration may be an attractive alternative to the management of local pain in order to avoid these side effects. However, previous studies have shown that DCF, in combination with sunlight, displays capability to induce photosensitivity disorders. In humans, DCF is biotransformed into hydroxylated metabolites at positions 4′ and 5 (4′OH-DCF and 5OH-DCF), and this chemical change produces non negligible alterations of the drug chromophore, resulting in a significant modification of its light-absorbing properties. In the present work, 5OH-DCF exhibited higher photo(geno)toxic potential than the parent drug, as shown by several in vitro assays (3T3 NRU phototoxicity, DNA ssb gel electrophoresis and COMET), whereas 4′OH-DCF did not display significant photo(geno)toxicity. This could be associated, at least partially with their more efficient UV-light absorption by 5OH-DCF metabolite and with a higher photoreactivity. Interestingly, most of the cellular DNA damage photosensitized by DCF and 5OH-DCF was repaired by the cells after several hours, although this effect was not complete in the case of 5OH-DCF.
Introduction
Diclofenac (2-(2,6-dichlorophenylamino)phenylacetic acid, DCF) is a widely prescribed nonsteroidal antiinflammatory drug (NSAID), which can be administered either topically or orally. It is therapeutically used in the treatment of several rheumatic diseases and as an analgesic. As DCF can cause severe adverse reactions such as gastrointestinal, renal and cardiovascular disorders, topical administration may be an attractive alternative to the management of local pain in order to avoid these side effects (Merk, 2007; Taylor et al., 2011) . However, previous studies have shown that DCF, in combination with sunlight, displays capability to induce photosensitivity reactions (Encinas et al., 1998a; Lhiaubet-Vallet and Miranda, 2012; Akat, 2013; Fernandez-Jorge et al., 2009; Al-Kathiri and Al-Asmaili, 2016; Kowalzick and Ziegler, 2006) .
In this context, taking into account that metabolites can generate, upon irradiation, reactive intermediates capable of binding to key biomacromolecules such as DNA, identification of metabolites with phototoxic or adduct forming capability still remains a major challenge. Therefore, although biotransformation is normally associated with a decreased toxicity, metabolites may be more phototoxic and photoreactive than the parent drug (Kato et al., 2017; Pearson and Wienkers, 2009; Miranda, 1997) .
Thus, in a previous work we have proven that demethylation of chlorpromazine (CPZ) as a consequence of Phase I biotransformation, does not result in a detoxification but leads to metabolites maintaining identical chromophore to the parent drug and exhibiting an even enhanced phototoxicity (Palumbo et al., 2016) .
In humans, DCF is biotransformed by glucuronosyl-transferase UGT2B7 to its acyl glucuronide and/or via oxidation of the aromatic rings by cytochrome P450 enzymes (CYPs) into hydroxylated metabolites (Kenny et al., 2004; Stierlin et al., 1979) . In this context, major metabolic pathways are hydroxylations in positions 4′ or 5 (4′OH-DCF and 5OH-DCF, see Fig. 1A ), and to a much lesser extent, in position 3 (Stierlin et al., 1979) .
Unlike the case of CPZ demethylation, the 4′OH-DCF and 5OH-DCF metabolites are associated with a change in the chromophore. Moreover, as shown in Fig. 1B both metabolites 4′OH-DCF and 5OH-DCF display a bathochromic shift of the absorption band towards the UVA region, thus extending the active fraction of solar light able to produce photosensitivity disorders. With this background, the goal of the present work is to assess the photo(geno)toxic potential of DCF metabolites in order to investigate whether DCF biotransformation modulates the potential to photosensitize DNA damage.
Materials and methods

General chemicals and reagents
All solvents were commercially available (HPLC grade) and were used without any further purification. Diclofenac sodium salt (DCF), 4′-hydroxydiclofenac (4′OH-DCF), 5-hydroxydiclofenac (5OH-DCF) chlorpromazine (CPZ), sodium dodecyl sulphate (SDS), neutral red solution and DNA repair enzymes E coli formamidopyrimidine DNA glycosylase (Fpg), E coli endonuclease III (Endo III), linoleic acid and human serum albumin (HSA) were provided by Sigma Aldrich (Madrid, Spain). For the preliminary experiments, 5-hydroxydiclofenac (5OH-DCF) was synthesized by standard procedures (Othman et al., 2000) . Data are the mean ± SD of five independent experiments performed in triplicate. CPZ and SDS were used as positive and negative controls of phototoxicity respectively. a According to the OECD 432 Guide (2004), PIF < 2 predicts "no phototoxicity", 2 < PIF < 5 predicts "probable phototoxicity" and PIF > 5 predicts "phototoxicity". 
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Supercoiled plasmid pBR322, DNA repair enzyme T4 endonuclease V (EndoV) and SYBR Safe DNA gel stain were purchased from Roche Diagnostics (Barcelona, Spain), Ecogen (Barcelona, Spain) and Invitrogen (Madrid, Spain), respectively. For cell culture experiments, fetal bovine serum (FBS), Dulbecco's Modified Eagle Medium (DMEM) and penicillin-streptomycin were supplied by Invitrogen (Madrid, Spain) and trypsine-EDTA (0.25%-0.02%) and glutamine (100 mM) solutions were provided by Cultek (Madrid, Spain). Phosphate buffered saline solution (PBS, pH 7.4, 0.01 M) was prepared by dissolving Sigma tablets in the appropriate volume of ultrapure deionized water. Reagent kit for single cell electrophoresis assay was supplied by Trevigen (Barcelona, Spain).
Irradiation equipment
The UV light source used in all in vitro photosensitization assays was a photoreactor model LZC-4 (Luzchem, Canada) equipped with 14 lamps for top and side irradiation (λ max = 350 nm, Gaussian distribution). All irradiations were carried out through the lid of the plates (96 well-plates and 6 well-plates for phototoxicity and photogenotoxicity experiments, respectively), and in order to avoid overheating ventilation was used and the plates were placed on ice during the irradiation step.
Absorption and emission spectral measurements
Ultraviolet absorption spectra were recorded on a Shimadzu UV-1800 UV/VIS spectrophotometer. Measurements were performed in PBS (4 × 10 − 5 M) at room temperature using 1 cm quartz cells with 3.5 mL capacity.
For fluorescence experiments 100 μM of DCF, 4′OH-DCF and 5OH-DCF in PBS were incubated for 2 h in 96 black well plates in the presence of linoleic acid (1 mM), HSA (100 μM) and whole cells (8.000 cells/well). Next, the samples were irradiated and the fluorescence emissions (λ exc = 320 nm and λ em = 390 nm) were recorded using a Synergy H1 multi-mode microplate reader (Biotek, Vermont, USA).
DNA damage induced by photosensitization
Mixtures containing 200 ng of supercoiled circular plasmid pBR322 and DCF (100 μM) or its metabolites (100 μM) were irradiated as described above. Digestion with an excess of the repair enzymes (Fpg, Endo III or Endo V) was performed immediately after UVA irradiation in order to reveal the nature of DNA damages. Upon irradiation/digestion, loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, 30% glycerol in water) was added to each sample. All the samples were loaded on a 0.8% agarose gel containing SYBR® Safe as dye of nucleic acid. Electrophoresis was carried out in Tris-acetate-EDTA (TAE) buffer (0.004 M Tris-acetate, 1 mM EDTA) at 100 V for 1 h. Next, the DNA bands were detected under UV light irradiation and visualized using a Gel Logic 200 Imaging System (Kodak). Finally, the relative abundance of supercoiled DNA (Form I) and nicked relaxed DNA (Form II) was quantified by densitometry with the image analyzer Quantity One (Biorad). Fig. 3 . Alkaline comet assay and DNA repair capability of FSK cells treated with DCF and its metabolites. A) Percentage of DNA damage calculated by OpenComet software of untreated FSK cells (Negative control, NC) or treated with DCF and its metabolites (100 μM). Cells were left unexposed (Dark, ■), irradiated for 5 min (UVA Light, □) or irradiated for 5 min followed by 6 h of cell recovery (UVA Light + Time recovery 6 h, ■), respectively. Data are the mean ± SD of three independent experiments. Asterisks indicate significant differences relative to the untreated FSK cells in dark conditions by the t-Student test (*p < 0.05; **p < 0.01; ***p < 0.001). B) Fluorescence microscopy images of DCF and 5OH-DCF Comet assay experiments.
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Nuclear DNA damage by COMET assay
The single cell gel electrophoresis assay, also known as comet assay, was performed as previously described (Palumbo et al., 2016) with slight modifications such as the kind of slides (Trevigen® treated slides vs agarose pre-coated slides), the size of the agarose drops (100 μL vs 5 μL) and the DNA percentage in tail quantification method (automated quantification, Open Comet Software, vs manual visual quantification). Human fibroblasts (FSK cell line) were trypsinized, resuspended in cold PBS and placed on ice for 2 h. Cells (100.000 cells/well in two 12-well plates) were seeded and treated with 100 μM of DCF or its metabolites. CPZ (10 μM) was used as a positive control. After 1 h incubation, one plate was placed in the photoreactor in order to irradiate the cells for 5 min on ice, whereas the other one was kept in a dark box. Next, 100 μL of each cell suspension were mixed carefully with 100 μL of 1% low melting point agarose solution and drops were loaded onto Trevigen® treated slides and placed on ice-cold tray to allow its jellification. Then the slides were immersed in coupling jars containing cold lysis buffer (2.5 M NaCl, 0.1 M Na 2 EDTA, 0.01 M Tris, 1% Triton X-100 in distilled water and pH 10) and overnight incubated at 4°C. In DNArecovery assays, after drop jellification, the slides were incubated in DMEM medium at 37°C for different time periods (3 h, 6 h or 18 h) and then subjected to cell lysis. Next day all slides were placed in a Trevigen® Comet assay electrophoresis tank (10 slides per run), covered with 850 mL of cold alkaline electrophoresis buffer (0.2 M NaOH, 1 mM EDTA in distilled water and pH ≥ 13) and let during 40 min for DNA unwinding at 4°C. Afterwards, the electrophoresis was run at 21 V (≈ 300 mA) for 30 min at 4°C. When the electrophoresis finished, the slides were neutralized twice in PBS for 5 min and washed once with miliQ water for 5 min; DNA was fixed by slide incubation in 70% ethanol for 5 min followed by other 5 min in 100% ethanol, and then air-dried. Finally, comet nucleoids and tails were stained by incubating the slides in a SYBR Gold® (1:10,000 TE buffer) bath for 30 min, air dried, and kept in darkness until further visualization. For nucleoids and tails DNA visualization a Leica DMI 4000B fluorescence microscope was used and ≥ 5 pictures were taken for each sample. Finally, DNA % in tail as a measure of DNA damage was determined for each condition with the analysis of at least 100 DNA comets with the open source analysis software Open Comet 1.3 (Gyori et al., 2014) .
Results and discussion
Phototoxicity
In vitro 3T3 NRU phototoxicity assay was performed in order to assess the cell viability upon exposure to DCF and its metabolites in combination with UVA irradiation (5 J/cm 2 ). Accordingly, cytotoxicity profiles of BALB/c 3T3 fibroblasts treated with DCF, 4′OH-DCF and 5OH-DCF were measured, using neutral red as vital dye, both in dark and in the presence of UVA light. Thus, the IC 50 values were determined from dose-response curves for cell viability of cells treated under the conditions described above in the materials and methods section (doseresponse curves are provided in Supplementary material, S2).
The aim of NRU test is to calculate the PIF that corresponds to the ratio of the IC 50 under dark or light conditions for each compound. As shown in Table 1 , 5OH-DCF metabolite resulted to be potentially phototoxic with a PIF value ca. 12.4 fold more phototoxic than the parent drug. Both DCF and 4′OH-DCF displayed a PIF of 3 and 2, respectively, which can be considered as probable phototoxicity. Table 1 collects the IC 50 under dark and UVA light conditions as well as the PIF of all compounds tested.
It is known that the photosensitizing properties of DCF are associated with the main photoproduct, which corresponds to a fluorescent chlorocarbazole derivative, as revealed in photohemolysis and lipid photoperoxidation assays (Encinas et al., 1998a) . Thus, the key process is the photodechlorination, triggered by homolytic carbon-chlorine bond cleavage with generation of a highly reactive aryl radical and choride anion (Encinas et al., 1998b) . To check whether this reaction occurs not only in the parent drug but also in the metabolites under study, the relative photoreactivity was investigated by comparing the fluorescence changes upon UVA-irradiation. The results obtained for DCF, 4′OH-DCF and 5OH-DCF in PBS and in the presence of lipids, proteins or whole cells are illustrated in the supplementary material (S3). In all cases, 5OH-DCF exhibited the most remarkable emission enhancement, pointing to a higher photoreactivity. Thus, the higher phototoxicity of 5OH-DCF is not only associated with its more efficient UV-light absorption, but also with its more efficient production of the active chlorocarbazole upon irradiation.
Photogenotoxicity of DCF and its metabolites
Irradiations of DCF, 4′OH-DCF and 5OH-DCF in the presence of supercoiled circular DNA (pBR322) were performed using a multilamp photoreactor (λ max = 355 nm) in order to detect DNA damage. Quantification by densitometry of the conversion of native supercoiled form I into circular form II ( Fig. 2A) shown in agarose gel (Fig. 2B ) evidenced single strand break (ssb) formation. It is interesting to note that 5OH-DCF exhibited higher photogenotoxic potential than the parent drug whereas 4′OH-DCF did not display significant photogenotoxicity (Fig. 2) .
Moreover, in order to reveal the nature of damages induced on the DNA bases, different DNA-repair enzymes were used: i) T4 endonuclease V (Endo V) for cyclobutane thymine dimers (CPDs), ii) endonuclease III (Endo III) for degradation products of pyrimidine bases and iii) formamidopyrimidine DNA glycosylase (FPG) for oxidized purines. Thus, ssb formation was enhanced for 5OH-DCF metabolite (data reported in Supplementary material, S4) in all cases.
Assessment of cellular photogenotoxicity was performed by Comet assay under alkaline conditions to reveal the combined nuclear DNA damage resulting from single-strand breaks, double-strand breaks and alkali-labile sites. For this purpose, human fibroblasts (FSK) were embedded in agarose on a slide and incubated for 1 h with DCF and its hydroxylated metabolites. Next, alkaline electrophoresis was carried out after 5 min of UVA exposure (2 J/cm 2 ) and subsequent lysis. In the course of electrophoresis, the damaged and fragmented DNA migrates away from the nucleus and upon staining with SYBR Gold the fluorescence of the nuclei was observed. Percentage of DNA damage was calculated by means of OpenComet software. As shown in Fig. 3 , 5OH-DCF showed again higher photogenotoxicity than the parent drug DCF and 4′OH-DCF metabolite (see Supplementary material, S5). Moreover, another set of experiments were performed in order to investigate the ability of FSK cells to repair nuclear DNA damage generated by DCF and metabolites in combination with UVA light. For this purpose, FSK cells treated (with drug and metabolites) and irradiated were incubated for different time periods (3 h, 6 h and 18 h) and the remaining DNA damage was calculated as described above. As a general trend DNA damage decreased with the time of recovery. Interestingly, for DCF it was shown that most DNA damage was repaired within 3 h after irradiation whereas for 5OH-DCF a significant residual DNA damage (around 25%) was still present even after 18 h of cell recovery ( Fig. 3 and Supplementary material, Fig. S6 ).
Conclusion
Hydroxylation of the aromatic rings at positions 4′ and 5 occurs during phase I biotransformation of DCF. This chemical change produces non negligible alterations of the drug chromophore and results in a significant modification of its light-absorbing properties and its photochemical reactivity. Accordingly, the phototoxic and photogenotoxic potential of DCF, 4′OH-DCF and 5OH-DCF are expectedly different, as indicated by 3T3 NRU phototoxicity assay, the DNA single strand break gel electrophoresis assay and the COMET assay. The most remarkable result is the enhanced photo(geno)toxicity of 5OH-DCF, which was consistently observed in all experiments. Interestingly, most of the cellular DNA damage photosensitized by DCF and 5OH-DCF was repaired by the cells after several hours, although this effect was not complete in the case of 5OH-DCF.
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